platoseedplatoseed
Smart gels for local drug delivery to the gut
Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.
Intact Therapeutics is a clinical-stage biopharmaceutical company focused on next-generation localized drug delivery technologies for gastrointestinal diseases. The company emphasizes patient-centric therapies aimed at addressing unmet clinical needs to improve outcomes and quality of life.
The company develops localized drug delivery technologies for the gut, enabling smart gels for delivering therapies directly to the gastrointestinal tract to treat GI diseases. The approach emphasizes next-generation, localized delivery to potentially improve efficacy and patient outcomes, with clinical-stage development.
Who it’s for: Biopharma/GI disease researchers and clinicians, pharma partners, and patients with gastrointestinal conditions seeking localized treatment options.
AI platform accelerating therapies for rare & inflammatory diseases.
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
